Concepedia

Author

Koji Nagaoka

University of Tokyo HospitalORCID

Also Known As

K. Nagaoka, Koji Nagaoka

50

Publications

507

Citations

13

H-Index

25

Concepts

All Affiliations

University of Tokyo HospitalThe University of TokyoRIKEN Center for Integrative Medical SciencesKeio UniversityJuntendo University
KN

About

Koji Nagaoka is an author at University of Tokyo Hospital specializing in medicine, tumor immunology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

99

2

Immunology

4

4

99

3

Cell Biology

3

3

86

4

Dendritic Cell Biology

1

1

31

5

Humoral Immunity

1

1

31

Koji Nagaoka

×

14

Publications

415

Citations

12

H-Index

YearCitations

Increased diversity with reduced “diversity evenness” of tumor infiltrating T-cells for the successful cancer immunotherapy

Akihiro Hosoi, Kazuyoshi Takeda, Koji Nagaoka,

Scientific Reports

2018

68

Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy

Koji Nagaoka, Masataka Shirai, Kiyomi Taniguchi,

Journal for ImmunoTherapy of Cancer

2020

65

Established gastric cancer cell lines transplantable into C57<scp>BL</scp>/6 mice show fibroblast growth factor receptor 4 promotion of tumor growth

Masami Yamamoto, Sachiyo Nomura, Akihiro Hosoi,

Cancer Science

2018

58

Adoptive transfer of zoledronate-expanded autologous Vγ9Vδ2 T-cells in patients with treatment-refractory non-small-cell lung cancer: a multicenter, open-label, single-arm, phase 2 study

Kazuhiro Kakimi, Hirokazu Matsushita, Keita Masuzawa,

Journal for ImmunoTherapy of Cancer

2020

40

Dendritic cell vaccine induces antigen-specific CD8<sup>+</sup> T cells that are metabolically distinct from those of peptide vaccine and is well-combined with PD-1 checkpoint blockade

Koji Nagaoka, Akihiro Hosoi, Tamaki Iino,

OncoImmunology

2017

31

An IL‐12‐Based Nanocytokine Safely Potentiates Anticancer Immunity through Spatiotemporal Control of Inflammation to Eradicate Advanced Cold Tumors

Pengwen Chen, Wenqian Yang, Koji Nagaoka,

Advanced Science

2023

31

Combination therapy with dendritic cell vaccine and IL-2 encapsulating polymeric micelles enhances intra-tumoral accumulation of antigen-specific CTLs

Kenji Miki, Koji Nagaoka, Mitsunori Harada,

International Immunopharmacology

2014

24

Integrative immunogenomic analysis of gastric cancer dictates novel immunological classification and the functional status of tumor‐infiltrating cells

Yasuyoshi Sato, Ikuo Wada, Kosuke Odaira,

Clinical & Translational Immunology

2020

18

Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1

Changbo Sun, Koji Nagaoka, Yukari Kobayashi,

Cancers

2021

16

Identification of Neoantigens in Two Murine Gastric Cancer Cell Lines Leading to the Neoantigen-Based Immunotherapy

Koji Nagaoka, Changbo Sun, Yukari Kobayashi,

Cancers

2021

15

Page 1